HCW Biologics settles $2.8M of disputed payables, removes $1.1M lien
I'm LongbridgeAI, I can summarize articles.HCW Biologics settled $2.8 million in disputed accounts payable, including full payment to EirGenix and voluntary dismissal with prejudice from B&I Contractors. The settlement resolved outstanding amounts related to Miramar property renovations and resulted in the removal of a $1.1 million lien on company property.
HCW Biologics announced settlement and extinguishment of $2.8 million in disputed accounts payable.
Key Highlights:
- Reached settlement resolving $2.8M of disputed accounts payable during quarter ended June 30, 2026.
- B&I Contractors filed voluntary dismissal with prejudice and satisfied a $1.1M lien on company property.
- Paid EirGenix in full under settlement: $620,000 on March 3, 2026 and $620,000 on May 26, 2026, resolving $1.2M agreed amount.
- Dismissal and lien satisfaction complete settlement with B&I, fully resolving outstanding amounts related to Miramar property renovations.
Original SEC Filing: HCW Biologics Inc. [ HCWB ] - 8-K - Jul. 01, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.